Barry Maron to Mass Screening
This is a "connection" page, showing publications Barry Maron has written about Mass Screening.
Connection Strength
3.518
-
Maron BJ, Estes NAM, Maron MS. Is It Fair to Screen Only Competitive Athletes for Sudden Death Risk, or Is It Time to Level the Playing Field? Am J Cardiol. 2018 04 15; 121(8):1008-1010.
Score: 0.406
-
Maron BJ, Haas TS, Duncanson ER, Garberich RF, Baker AM, Mackey-Bojack S. Comparison of the Frequency of Sudden Cardiovascular Deaths in Young Competitive Athletes Versus Nonathletes: Should We Really Screen Only Athletes? Am J Cardiol. 2016 Apr 15; 117(8):1339-41.
Score: 0.354
-
Maron BJ, Levine BD, Washington RL, Baggish AL, Kovacs RJ, Maron MS. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2356-2361.
Score: 0.348
-
Maron BJ, Friedman RA, Caplan A. Ethics of preparticipation cardiovascular screening for athletes. Nat Rev Cardiol. 2015 Jun; 12(6):375-8.
Score: 0.331
-
Maron BJ. National electrocardiography screening for competitive athletes: Feasible in the United States? Ann Intern Med. 2010 Mar 02; 152(5):324-6.
Score: 0.235
-
Maron BJ, Haas TS, Doerer JJ, Thompson PD, Hodges JS. Comparison of U.S. and Italian experiences with sudden cardiac deaths in young competitive athletes and implications for preparticipation screening strategies. Am J Cardiol. 2009 Jul 15; 104(2):276-80.
Score: 0.222
-
Pelliccia A, Zipes DP, Maron BJ. Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol. 2008 Dec 09; 52(24):1990-6.
Score: 0.216
-
Glover DW, Glover DW, Maron BJ. Evolution in the process of screening United States high school student-athletes for cardiovascular disease. Am J Cardiol. 2007 Dec 01; 100(11):1709-12.
Score: 0.199
-
Maron BJ. Hypertrophic cardiomyopathy and other causes of sudden cardiac death in young competitive athletes, with considerations for preparticipation screening and criteria for disqualification. Cardiol Clin. 2007 Aug; 25(3):399-414, vi.
Score: 0.196
-
Maron BJ, Thompson PD, Ackerman MJ, Balady G, Berger S, Cohen D, Dimeff R, Douglas PS, Glover DW, Hutter AM, Krauss MD, Maron MS, Mitten MJ, Roberts WO, Puffer JC. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation. 2007 Mar 27; 115(12):1643-455.
Score: 0.191
-
Harris KM, Sponsel A, Hutter AM, Maron BJ. Brief communication: Cardiovascular screening practices of major North American professional sports teams. Ann Intern Med. 2006 Oct 03; 145(7):507-11.
Score: 0.185
-
Pelliccia A, Di Paolo FM, Corrado D, Buccolieri C, Quattrini FM, Pisicchio C, Spataro A, Biffi A, Granata M, Maron BJ. Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes. Eur Heart J. 2006 Sep; 27(18):2196-200.
Score: 0.182
-
Harris KM, Tung M, Haas TS, Maron BJ. Under-recognition of aortic and aortic valve disease and the risk for sudden death in competitive athletes. J Am Coll Cardiol. 2015 Mar 03; 65(8):860-862.
Score: 0.083
-
Maron BJ, Friedman RA, Kligfield P, Levine BD, Viskin S, Chaitman BR, Okin PM, Saul JP, Salberg L, Van Hare GF, Soliman EZ, Chen J, Matherne GP, Bolling SF, Mitten MJ, Caplan A, Balady GJ, Thompson PD. Assessment of the 12-lead electrocardiogram as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 years of age): a scientific statement from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol. 2014 Oct 07; 64(14):1479-514.
Score: 0.080
-
Maron BJ, Murphy CJ, Haas TS, Ahluwalia A, Garberich RF. Strategies for assessing the prevalence of cardiovascular sudden deaths in young competitive athletes. Int J Cardiol. 2014 May 15; 173(3):369-72.
Score: 0.077
-
Rowin EJ, Maron BJ, Appelbaum E, Link MS, Gibson CM, Lesser JR, Haas TS, Udelson JE, Manning WJ, Maron MS. Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy. Am J Cardiol. 2012 Oct 01; 110(7):1027-32.
Score: 0.069
-
Drezner JA, Courson RW, Roberts WO, Mosesso VN, Link MS, Maron BJ. Inter-association task force recommendations on emergency preparedness and management of sudden cardiac arrest in high school and college athletic programs: a consensus statement. Clin J Sport Med. 2007 Mar; 17(2):87-103.
Score: 0.048
-
Adabag AS, Kuskowski MA, Maron BJ. Determinants for clinical diagnosis of hypertrophic cardiomyopathy. Am J Cardiol. 2006 Dec 01; 98(11):1507-11.
Score: 0.046
-
Maron BJ. Sudden death in young athletes. N Engl J Med. 2003 Sep 11; 349(11):1064-75.
Score: 0.037
-
Drezner JA, Courson RW, Roberts WO, Mosesso VN, Link MS, Maron BJ. Inter-association task force recommendations on emergency preparedness and management of sudden cardiac arrest in high school and college athletic programs: a consensus statement. Heart Rhythm. 2007 Apr; 4(4):549-65.
Score: 0.012